Ernesto Aycardi-fonseca - Net Worth and Insider Trading

Ernesto Aycardi-fonseca Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Ernesto Aycardi-fonseca owns 1 companies in total, including Xenon Pharmaceuticals Inc (XENE) .

Click here to see the complete history of Ernesto Aycardi-fonseca’s form 4 insider trades.

Insider Ownership Summary of Ernesto Aycardi-fonseca

Ticker	Comapny	Transaction Date	Type of Owner
XENE	Xenon Pharmaceuticals Inc	2018-03-19	Chief Medical Officer

Ernesto Aycardi-fonseca Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Ernesto Aycardi-fonseca Ownership Network

Ownership Network List of Ernesto Aycardi-fonseca

No Data

Ownership Network Relation of Ernesto Aycardi-fonseca

Ernesto Aycardi-fonseca Owned Company Details

What does Xenon Pharmaceuticals Inc do?

Who are the key executives at Xenon Pharmaceuticals Inc?

Ernesto Aycardi-fonseca is the Chief Medical Officer of Xenon Pharmaceuticals Inc. Other key executives at Xenon Pharmaceuticals Inc include SVP Bus. & Corp. Development Sherrington Robin , director & PRESIDENT & CEO Ian Mortimer , and Chief Medical Officer Christopher John Kenney .

Xenon Pharmaceuticals Inc (XENE) Insider Trades Summary

Over the past 18 months, Ernesto Aycardi-fonseca made no insider transaction in Xenon Pharmaceuticals Inc (XENE). Other recent insider transactions involving Xenon Pharmaceuticals Inc (XENE) include a net sale of 26,576 shares made by Gary Patou , a net sale of 131,245 shares made by Simon N. Pimstone , and a net sale of 31,655 shares made by Ian Mortimer .

In summary, during the past 3 months, insiders sold 0 shares of Xenon Pharmaceuticals Inc (XENE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 236,705 shares of Xenon Pharmaceuticals Inc (XENE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 236,705 shares.

Xenon Pharmaceuticals Inc (XENE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Xenon Pharmaceuticals Inc Insider Transactions

No Available Data

Ernesto Aycardi-fonseca Mailing Address

Above is the net worth, insider trading, and ownership report for Ernesto Aycardi-fonseca. You might contact Ernesto Aycardi-fonseca via mailing address: 200 - 3650 Gilmore Way, Burnaby A0 V5g 48w.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.